C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations | Zendy

Christopher Butler | Zendy; David Gillespie | Zendy; Patrick White | Zendy; Janine Bates | Zendy; Rachel Lowe | Zendy; Emma ThomasJones | Zendy; Mandy Wootton | Zendy; Kerenza Hood | Zendy; Rhian Phillips | Zendy; Hasse Melbye | Zendy; Carl Llor | Zendy; Jochen Cals | Zendy; Gurudutt Naik | Zendy; Nigel Kirby | Zendy; Micaela Gal | Zendy; Evgenia Riga | Zendy; Nick Francis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations

Author(s) -

Christopher Butler,

David Gillespie,

Patrick White,

Janine Bates,

Rachel Lowe,

Emma ThomasJones,

Mandy Wootton,

Kerenza Hood,

Rhian Phillips,

Hasse Melbye,

Carl Llor,

Jochen Cals,

Gurudutt Naik,

Nigel Kirby,

Micaela Gal,

Evgenia Riga,

Nick Francis

Publication year - 2019

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1803185

Subject(s) - copd , pulmonary disease , antibiotics , medicine , c reactive protein , intensive care medicine , point of care testing , immunology , inflammation , microbiology and biotechnology , biology

Point-of-care testing of C-reactive protein (CRP) may be a way to reduce unnecessary use of antibiotics without harming patients who have acute exacerbations of chronic obstructive pulmonary disease (COPD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research